title: [Anticoagulant-induced prophylaxis of thrombosis (author's transl)].
abstract: In postoperative and posttraumatic states, thromboembolic prophylaxis results in tenfold lower occurrence of pulmonary embolism and venous thrombisis--on which the postthrombotic syndrome is based--without a determinable increase of bleeding risk. Heparin is the treatment of choice. The dosage should be calculated on the basis of body weight. A minimal laboratory program of control measurements can diminish side effects.
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D003374:Coumarins / Q000008:administration & dosage / Q000627:therapeutic use; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D011183:Postoperative Complications / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D003374:Coumarins; D006493:Heparin
vernacular_title: Medikamentöse Thrombose-Prophylaxe mit Anticoagulantien.